Patent details

Basic Information

Publication number:

EP2295441

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101729713

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Bicyclonucleoside Oligonucleotide Analogue

French Title of Invention:

analogues d'oligonucléotides de bicyclonucléoside

German Title of Invention:

Bicyclonucleosid Oligonukleotidanaloga

SPC Number:

Dates

Filing date:

09/03/1998

Grant date:

07/05/2014

EP Publication Date:

07/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/03/2011

EP B1 Publication Date:

07/05/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/03/2018

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/11/2014

 

 

Name:

Exiqon A/S

Address:

Skelstedet 16, 2950 Vedbaek, Denmark (DK)

Name:

Roche Innovation Center Copenhagen A/S

Address:

Fremtidsvej 3, 2970 Hørsholm, Denmark (DK)

Agent

Name:

VALIPAT

From:

30/06/2014

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

Obika Satoshi

Address:

Japan (JP)

2

Name:

Imanishi Takeshi

Address:

Japan (JP)

Priority

Priority Number:

5340997

Priority Date:

07/03/1997

Priority Country:

Japan (JP)

Classification

Main IPC Class:

C07H 19/06;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

07/03/2017

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages